As a leading mid-sized, full-service CRO across Europe and North America, we give unrivalled access to Patients and Investigators in all countries in Europe and North America. This is an important factor in our ability to reliably expedite patient recruitment and deliver accurate results to clinical research projects in a cost-effective and timely manner.
With three hubs strategically located in Western Europe’s and Nordic’s more mature markets and our recent expansion in the US, we can accommodate any trials from a broad geographic and demographic spread. Numerous strategic scenarios for high-quality recruitment can be implemented, whether to enrol fast or supplement (save) any ongoing recruitment within or without Europe or both. Some of our countries present the benefit of accessing participants for less common therapeutic areas.
Global projects are also managed by Optimapharm with the support of a network of strategic partnerships that cover regions outside of Europe, including APAC and Latin America.